E. Bartholome

发表

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

D. Arnold, S. Muley, P. Vermersch, 2018, The Lancet Neurology.

Antiphospholipid antibodies and ischemic neuropathy following cardiac surgery.

J. Bier, M. Vokaer, E. Bartholome, 2003, Acta neurologica Belgica.

The cerebellum may be directly involved in cognitive functions.

P. Paquier, M. Pandolfo, S. Goldman, 2002, Neurology.

Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management

B. Decallonne, M. D’haeseleer, V. Delvaux, 2018, Acta Neurologica Belgica.

OCULAR LATEROPULSION FROM A BRAINSTEM STROKE CAN COMPENSATE FOR HEMIANOPIA

J. Bier, P. Fery, M. Vokaer, 2007, Neurology.

Cerebellar Hemorrhage due to Factor XI Deficiency

A. Kentos, J. Bier, S. Blecic, 2005, Cerebrovascular Diseases.

IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion.

M. Goldman, A. Crusiaux, K. Thielemans, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

properties monocytes into dendritic cells with potent helper T-cell stimulatory cooperate to induce differentiation of β Interleukin-3 and interferon

I. Salmon, M. Goldman, C. Buelens, 2013 .

Dolutegravir-induced extrapyramidal syndrome in a young woman.

S. De Wit, E. Bartholome, N. Dauby, 2019, AIDS.

Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta.

R. Kiss, G. Opdenakker, M. Goldman, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Immunoregulatory properties of type-I interferons: relevance to multiple sclerosis and the hypereosinophilic syndrome.

F. Roufosse, E. Bartholome, 1997, Acta clinica Belgica.

Could visual neglect induce amblyopia?

J. Bier, P. Fery, S. Blecic, 2004, Acta neurologica Belgica.

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

Jeffrey A. Cohen, Islam M. Zaydan, Gregory F. Wu, 2022, The Lancet Neurology.

Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program

C. Sindic, J. Debruyne, M. D'hooghe, 2014, Acta Neurologica Belgica.

Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties.

I. Salmon, M. Goldman, K. Thielemans, 2002, Blood.

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice

H. Wiendl, L. Airas, H. Mattle, 2011, Therapeutic advances in neurological disorders.